Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis

被引：7

作者：

Hosoki, Satoshi ^{[1
]}

Takagi, Masahito ^{[1
]}

Yamagami, Hiroshi ^{[2
]}

Ando, Daisuke ^{[1
]}

Toyoda, Kazunori ^{[1
]}

Koga, Masatoshi ^{[1
]}

机构：

[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan

[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka, Japan

来源：

JOURNAL OF NEUROLOGY | 2018年 / 265卷 / 10期

关键词：

D O I：

10.1007/s00415-018-9011-8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2451 / 2453

页数：3

共 50 条

[41] Dabigatran etexilate/idarucizumab interactionParadoxical elevation of plasma dabigatran etexilate: case report
Reactions Weekly, 2018, 1725 (1) : 109 - 109
[42] Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study
Jala, Sheila
O'Brien, Elizabeth
JOURNAL OF NEUROSCIENCE NURSING, 2019, 51 (01) : 21 - 25
[43] Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort
Barber, P. Alan
Wu, Teddy Y.
Ranta, Annemarei
NEUROLOGY, 2020, 94 (19) : E1968 - E1972
[44] INTRAVENOUS THROMBOLYSIS AFTER IDARUCIZUMAB APPLICATION IN STROKE PATIENTS RECEIVING DABIGATRAN THERAPY: SLOVENIAN CASE SERIES
Oblak, J. Pretnar
Frol, S.
Sabovic, M.
INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 118 - 118
[45] Reversal of dabigatran using idarucizumab in acute stroke (mimics): a case report
Engelen, M.
Vanassche, T.
ACTA CARDIOLOGICA, 2019, 74 (05) : 462 - 462
[46] Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke
Schulz, Joachim G.
Kreps, Bernard
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 370 : 44 - 44
[47] Reversal of dabigatran by idarucizumab: when and how?
Vanassche, Thomas
Greinacher, Andreas
Verhamme, Peter
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 519 - 528
[48] Evidence Supporting Idarucizumab for the Reversal of Dabigatran
Pollack, Charles V., Jr.
AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11): : S73 - S79
[49] Idarucizumab: A Review as a Reversal Agent for Dabigatran
Yahiya Y. Syed
American Journal of Cardiovascular Drugs, 2016, 16 : 297 - 304
[50] Evidence supporting idarucizumab for the reversal of dabigatran
Pollack, Charles V., Jr.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 33 - 38

← 1 2 3 4 5 →